NCT06012929 2026-01-26
A Study of ONC201 for Refractory Meningioma
University of Nebraska
Phase 2 Withdrawn
Clinical Trials
6 trialsNCT05009992 2025-12-17
PNOC022
University of California, San Francisco
Phase 2 Recruiting
NCT03099499 2024-12-24
Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer
Fox Chase Cancer Center
Phase 2 Terminated
NCT03034200 2024-11-26
Phase 2 Study of ONC201 in Neuroendocrine Tumors
Case Comprehensive Cancer Center
Phase 2 Completed
NCT04629209 2023-11-24
A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
Masonic Cancer Center, University of Minnesota
Phase 2 Withdrawn
NCT03733119 2022-03-10
ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer
University of Wisconsin, Madison
Phase 2 Terminated